Ethics in Neurobiological Research with Human Subjects: The Baltimore Conference on EthicsThe papers included in this book were presented at the Baltimore Conference on Ethics in 1995. The purpose of this conference was to bring together ethicists, psychiatrists, researchers, family members, consumers, and representatives of government, industry and academia to discuss the following issues: History and Ethics of Neurobiological Research with Human Subjects, Current Practices, Informed Consent, Government Oversight/Institutional Review Boards, and the Patient and Family Perspective. Over the past 40 years, there has been a significant increase in research on neurobiological disorders for basic scientific knowledge, and to develop new treatment therapies. This has led to significant advances in the treatment of schizophrenia, manic-depression and other disorders which have improved the lives of thousands. Public attention has been raised recently over the potential vulnerability of patients with neurobiological disorders who participate in such research since these patients often s |
From inside the book
Results 1-5 of 91
Page
... Problems of Incapacity and Voluntariness 1 5 27 45 55 George J. Annas and Leonard H. Glantz Government Oversight 81 Robert A. Destro 5 Institutional Review Boards and Research on Individuals with Mental Disorders 101 Sue Keir Hoppe 6 An ...
... Problems of Incapacity and Voluntariness 1 5 27 45 55 George J. Annas and Leonard H. Glantz Government Oversight 81 Robert A. Destro 5 Institutional Review Boards and Research on Individuals with Mental Disorders 101 Sue Keir Hoppe 6 An ...
Page
... Problems in Interpreting Active Control Equivalence Trials Robert Temple 279 27 Sounding Board - The Continuing Unethical Use of Placebo Controls 289 K. J. Rothman and K. B. Michels Reforming the IRB Process : Towards New Guidelines for ...
... Problems in Interpreting Active Control Equivalence Trials Robert Temple 279 27 Sounding Board - The Continuing Unethical Use of Placebo Controls 289 K. J. Rothman and K. B. Michels Reforming the IRB Process : Towards New Guidelines for ...
Page 5
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 7
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 8
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
Introduction | 1 |
Accountability in Research Using Persons with Mental Illness | 27 |
Proposed Regulations for Research Involving Those | 45 |
The Dual Problems of Incapacity | 55 |
Government Oversight | 81 |
Institutional Review Boards and Research on Individuals with | 101 |
An Urgent Academic Challenge Treatment of Refactory Patients | 111 |
WashoutRelapses in Patients Participating in Neurobiological | 119 |
National Institute of Mental Health Human Subjects Activities | 201 |
The Use of Placebo Controls in Psychiatric Research | 207 |
A Challenge for Constructive Criticism | 215 |
An NIMH | 229 |
22 A Communal Model for Presumed Consent for Research on | 239 |
23 Patients Competence to Consent to Neurobiological Research | 253 |
24 The International Covenant on Civil and Political Rights and | 265 |
Perspectives | 273 |
Standards of Accountability for Consent in Research | 129 |
Human Rights in Reference to Persons with Mental Illness | 139 |
Approximating Ethical Research Consent | 149 |
Statement of the UCLA Clinical Research Center | 173 |
Expanding on A Mothers Testimony | 183 |
Ethical Considerations in MedicationFree Research on | 195 |
26 Problems in Interpreting Active Control Equivalence Trials | 279 |
Comments of Laurie M Flynn | 305 |
Science and Ethics The Search for a Balance | 315 |
NAMIs Standards for Protection of Individuals with Severe | 325 |
Common terms and phrases
Accountability in Research antipsychotic Appelbaum authors autonomy Belmont Report Biomedical and Behavioral clinical research cognitively impaired Committee competent concern conduct conference consent auditor consent form consumers court decision Declaration of Helsinki disease drug effects ethical experience Federal Regulations fluphenazine harm human experimentation Human Rights human subjects research ICCPR incompetent individual informed consent informed consent process Institutional Review Board institutionalized as mentally investigators issues Journal Katz L-dopa medical research Medicine mental health mental illness mentally disabled minimal risk NAMI National Commission neurobiological neurobiological research neuroleptic NIMH Nuremberg Code OPRR participate in research patient-subjects persons with mental physician placebo placebo controls potential problem procedures professional proposed Protection of Human psychiatric research psychotic relapse research involving research protocol research subjects response Rothman schizophrenia scientific Shamoo standards symptoms tardive dyskinesia therapeutic therapy tion treatment UCLA vulnerable